Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-7-7
pubmed:abstractText
CCK increases the rate of net protein synthesis in rat pancreatic acini by activating initiation and elongation factors required for translation. The immunosuppressant FK506 inhibits the Ca(2+)-calmodulin-dependent phosphatase calcineurin in pancreatic acinar cells and blocks pancreatic growth induced by chronic CCK treatment. To test a requirement for calcineurin in the activation of the translational machinery stimulated by CCK, we evaluated the effects of FK506 on protein synthesis and on regulatory initiation and elongation factors in rat pancreatic acini in vitro. CCK acutely increased protein synthesis in acini from normal rats with a maximum increase at 100 pM CCK to 170 +/- 11% of control. The immunosuppressant FK506 dose-dependently inhibited CCK-stimulated protein synthesis over the same concentration range that blocked calcineurin activity, as assessed by dephosphorylation of the calcineurin substrate calcium-regulated heat-stable protein of 24 kDa. Another immunosuppressant, cyclosporin A, inhibited protein synthesis, but its effects appeared more complex. FK506 also inhibited protein synthesis stimulated by bombesin and carbachol. FK506 did not significantly affect the activity of the initiation factor-2B, or the phosphorylation of the initiation factor-2alpha, ribosomal protein protein S6, or the mRNA cap binding protein eukaryotic initiation factor (eIF) 4E. Instead, blockade of calcineurin with FK506 reduced the phosphorylation of the eIF4E binding protein, reduced the formation of the eIF4F complex, and increased the phosphorylation of eukaryotic elongation factor 2. From these results, we conclude that calcineurin activity is required for protein synthesis, and this action may be related to an effect on the formation of the mRNA cap binding complex and the elongation processes.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Calcineurin, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Calmodulin-Dependent..., http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cholecystokinin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine, http://linkedlifedata.com/resource/pubmed/chemical/EEF2K protein, human, http://linkedlifedata.com/resource/pubmed/chemical/EIF4E2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Eef2k protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Eif4ebp1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Elongation Factor 2 Kinase, http://linkedlifedata.com/resource/pubmed/chemical/Eukaryotic Initiation Factor-2B, http://linkedlifedata.com/resource/pubmed/chemical/Eukaryotic Initiation Factor-4F, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Elongation Factor 2, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins, http://linkedlifedata.com/resource/pubmed/chemical/RNA Cap-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6, http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0363-6143
pubmed:author
pubmed:issnType
Print
pubmed:volume
287
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
C310-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15044154-Animals, pubmed-meshheading:15044154-Calcineurin, pubmed-meshheading:15044154-Calcium-Calmodulin-Dependent Protein Kinases, pubmed-meshheading:15044154-Carrier Proteins, pubmed-meshheading:15044154-Cholecystokinin, pubmed-meshheading:15044154-Cyclosporine, pubmed-meshheading:15044154-Elongation Factor 2 Kinase, pubmed-meshheading:15044154-Eukaryotic Initiation Factor-2B, pubmed-meshheading:15044154-Eukaryotic Initiation Factor-4F, pubmed-meshheading:15044154-Immunosuppressive Agents, pubmed-meshheading:15044154-Male, pubmed-meshheading:15044154-Pancreas, pubmed-meshheading:15044154-Peptide Elongation Factor 2, pubmed-meshheading:15044154-Phosphoproteins, pubmed-meshheading:15044154-Phosphorylation, pubmed-meshheading:15044154-Protein Biosynthesis, pubmed-meshheading:15044154-RNA Cap-Binding Proteins, pubmed-meshheading:15044154-Rats, pubmed-meshheading:15044154-Rats, Sprague-Dawley, pubmed-meshheading:15044154-Ribosomal Protein S6, pubmed-meshheading:15044154-Tacrolimus
pubmed:year
2004
pubmed:articleTitle
Calcineurin is required for translational control of protein synthesis in rat pancreatic acini.
pubmed:affiliation
Department of Molecular and Integrative Physiology, University of Michigan Medical School, 1301 E. Catherine St., 7737 Med Sci II, Ann Arbor, MI 48109-0622, USA. mdsansg@umich.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.